logo
Slowing aging: Psilocybin helps extend life span in human cells by over 50%

Slowing aging: Psilocybin helps extend life span in human cells by over 50%

Psilocybin is a chemical that is found in a wide variety of mushrooms known for their euphoric and hallucinogenic effects. Over the past few years, there have been a number of studies investigating the use of psilocybin for the treatment of mental health disorders and medical conditions. A new study says psilocybin may help delay aging by increasing the cellular life span of human skin and lung cells by more than 50%. Scientists also reported evidence psilocybin may help protect the body from age-related diseases through several health-protecting qualities, via a mouse model.Psilocybin is a chemical that is found in a wide variety of mushrooms. Also known as 'shrooms' and 'magic mushrooms,' psilocybin is known for its euphoric and hallucinogenic effects. Over the past few years, there have been a number of studies investigating the use of psilocybin for the treatment of mental health disorders such as treatment-resistant depression, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and substance use disorders, as well as medical conditions like migraine, Alzheimer's disease, irritable bowel syndrome (IBS), and Parkinson's disease. 'The overwhelming majority of what we know about psilocybin is from clinical outcomes (with >150 clinical trials ongoing or completed) and impacts on the brain,' Louise Hecker, PhD, associate professor at Baylor College of Medicine, told Medical News Today. 'Psilocybin is well known for its hallucinogenic properties. However, we know very little about what it does otherwise, particularly its impact systemically on the rest of the body.'Hecker is the senior author of a new study recently published in the journal npj Aging that has found indication that psilocybin may help delay aging by increasing the cellular lifespan of human skin and lung cells by more than 50%. Scientists also reported evidence psilocybin may help protect the body from age-related diseases, such as neurodegeneration, heart disease, and cancer through several health-protecting qualities, via a mouse model.Psilocybin helps extend life in cells by over 50%For this study, researchers first used a cellular aging model of human lung cells to see how psilocin — the active ingredient in mushrooms that causes hallucinogenic effects — would impact them. Scientists reported that psilocin helped to extend the cellular lifespan of human skin and lung cells by more than 50%.'The significance is that psilocin-treated cells do age, however they age at a slower rate, while maintaining the properties of 'young' cells longer,' Hecker, who was an associate professor at Emory University at the time of the study, said. When moving to a mouse model, Hecker and her team also discovered that mice at the equivalent of 60-65 human years given psilocybin lived longer than those who did not receive it. Additionally, these mice displayed healthier features, such as fewer white hairs and hair regrowth.'We designed this experiment with the clinical relevance in mind — wouldn't it be great if we could give an intervention to elderly adults that helps them to live healthier longer?,' Hecker explained. 'Our study suggests that this is possible.'Psilocybin helps maintain telomere length, helping with agingAccording to researchers, their findings suggest that psilocybin assists with slowing aging by reducing oxidative stress, improving DNA repair responses, and maintaining the length of telomeres. Telomeres are the 'end caps' of chromosomes. By helping to preserve telomere lengths, the researchers believe this may help protect the body from age-related diseases like heart disease, neurodegeneration, and cancer. 'Psilocybin appears to reduce the 'wear and tear' that accompanies aging. Although psilocybin is well-known for its psychedelic effects, our study suggests that psilocybin has potent impacts on the entire body. Psilocybin holds great potential for promoting healthy aging — this is just the starting point, as much more research is needed.'— Louise Hecker, PhD'We need to better understand its mechanisms of action, in particular how it works outside the brain to impact systemic aging and other processes,' Hecker said. 'More research is needed to optimize dosing/frequency protocols as well as monitor for the potential of adverse effects before it is ready to be used clinically as an anti-aging agent.'More studies needed to translate findings to humansMNT spoke with Jack Jacoub, MD, a board certified medical oncologist and medical director of MemorialCare Cancer Institute at Orange Coast and Saddleback Medical Centers in Orange County, CA, about this study. 'Cell aging is a key feature to overall health and illnesses and cancer,' Jacoub said. 'And so there's a lot of therapies now that are looking at things like senescence, which is normal cell aging, how to slow it down, and how to repair the damage that happens with aging. Sometimes issues related to cancer are due to the inability to repair damage, and it becomes a cancerous cell.' Jacoub commented that while this was a very interesting and notable observational study, it's a big leap right now to say these findings will translate to human illnesses, including cancer. 'It's too general right now to say anti-aging — that's an incredible umbrella. For it to really make an impact, and for you to see it available and recommended, it's going to need to be advanced further, obviously in humans, but then in particular areas to be able to say, yes, there really is merit to this, we should be recommending this to patients, etc.' — Jack Jacoub, MD'Like for example, could it help repair injury quickly?,' Jacoub continued. 'That would be (an) interesting thing to observe and study. And so let's say it's stroke patients, heart attack patients, whatever it might be — is there some role there to use it and accelerate healing from events like that? (And) a good one would be cellular repair. Can you recover and heal faster if you took this? That would be an example of it.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership
Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership

Reuters

time26 minutes ago

  • Reuters

Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership

July 15 (Reuters) - Telehealth company Hims & Hers (HIMS.N), opens new tab is facing a growing number of U.S. investor lawsuits after Novo Nordisk's ( opens new tab decision last month to end a short-lived partnership to sell its Wegovy weight-loss drug through the platform sent shares plunging. A group of shareholders sued Hims on Monday in federal court in San Francisco, accusing its board and senior executives of making false and misleading statements about its financial condition and operations. The case was filed as a so-called derivative lawsuit on behalf of the company. The lawsuit follows two securities class actions filed by Hims investors in the same court last month, seeking damages over the drop in stock price after Novo in late June ended what the companies had initially described as a long-term collaboration designed to make obesity care and treatment more affordable and accessible. Hims, Novo and the lawyers who filed Monday's lawsuit did not immediately respond to requests for comment. Danish drugmaker Novo is not a defendant in the lawsuits. Founded in 2017, San Francisco-based Hims provides health and wellness products focused on weight loss, sexual and mental health and hair loss. Novo on June 23 said it was ending their partnership that began in late April, citing Hims' alleged improper marketing and sales of Wegovy copies. Novo accused Hims of 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk.' Hims CEO Andrew Dudum responded, opens new tab in a post on X that day that accused Novo management of misleading the public and making anticompetitive demands 'that infringe on the independent decision making of providers and limit patient choice.' Hims shares fell $22.24, or over 34%, after Novo's announcement, declining from $64.22 per share on June 20 to close at $41.98 per share on June 23. The stock closed on Monday at $52.03 a share. The tight supply of Wegovy in the United States had allowed Hims and others to sell cheaper, compounded versions of the drug, known chemically as semaglutide. The U.S. Food and Drug Administration in February removed Wegovy from the agency's shortage list. Hims said the decision meant it could not guarantee continued sales of compounded semaglutide. The case is Steve Jones v. Andrew Dudum, U.S. District Court, Northern District of California, No. 3:25-cv-05866-AGT. For plaintiff: Shane Rowley of Rowley Law PLLC, and Francis "Casey" Flynn Jr. of Law Office of Francis J. Flynn Jr For defendants: No appearances yet Read more: Novo, Hims & Hers engage in war of words after Wegovy deal falls apart US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers

Kroger issues recall over possibly deadly products in 18 states
Kroger issues recall over possibly deadly products in 18 states

Daily Mail​

timean hour ago

  • Daily Mail​

Kroger issues recall over possibly deadly products in 18 states

Products sold in Kroger stores in more than a dozen states have been recalled due to allergens and deadly bacteria. Health officials have issued two different recall notices this month for baked goods and bacon sold at Kroger, an Ohio-based chain with 2,800 stores nationwide. Earlier this month, Oscar Mayer issued a voluntary recall for its 12-ounce and 36-ounce Turkey Bacon products due to potential contamination with listeria monocytogenes, a bacterium that causes foodborne illness listeria. While most of the 1,600 Americans who fall ill with listeria every year recover on their own, at-risk groups like pregnant women and immunocompromised people may suffer miscarriage, sepsis and seizures. Meanwhile, Lewis Bake Shop Artisan Style Half Loaf bread was recalled a few days later due to the potential presence of undeclared hazelnuts, which could cause severe reactions in the 1.6 million Americans with hazelnut allergies. All recalled products were sold in 18 states: Michigan, Wisconsin, Illinois, Indiana, Ohio, Kentucky, Tennessee, Georgia, Arkansas, Missouri, Alabama, Mississippi, South Carolina, Virginia, North Carolina, West Virginia, Texas and Louisiana. Consumers for both recalls were urged to return products to the place of purchase for a full refund. No illnesses have been reported for either recall. Recalled Oscar Mayer products include 12-ounce packages of Oscar Mayer Turkey Bacon with the product code 71871-54860 and use-by dates of July 19, July 20, July 24, August 1, and August 2, 2025. The recalled 36-ounce packages are labeled with product code 71871-54874 and have use-by dates of July 29 and August 31, 2025. This recall affects Kroger stores in Georgia, South Carolina, Alabama, Ohio, Virginia, Michigan, Indiana, Illinois, Missouri, Kentucky, Tennessee, Arkansas, Mississippi, North Carolina, West Virginia, Texas and Louisiana. These products were found to potentially be contaminated with listeria. Listeria, also called Listeriosis, is a serious infection caused by eating food contaminated with Listeria monocytogenes. It can be found in moist environments, soil, water, decaying vegetation and animals, and can survive refrigeration and other food preservation measures. Many foods can harbor the bug, but it is usually found in unpasteurized milk, soft cheeses and ready-to-eat foods, such as prepacked sandwiches. Cooked shellfish, cured meats and fish, including sushi and pre-cut fruit, are also a risk. Most people who eat food contaminated with listeria will not become seriously ill. But in some cases, it can cause confusion and seizures, miscarriage in pregnant women, and even death. This can happen when the infection spreads beyond the gut and affects the central nervous system, which can lead to numbness and seizures. The CDC estimates 1,600 Americans become infected with listeria every year, and about 260 die. Meanwhile, the Lewis Bake Shop Artisan Style Half Loaf contaminated bread was sold in 12-ounce clear plastic bags with a July 13, 2025, expiration date printed on the front of the packaging and a UPC code 24126018152 printed on the bottom. The six affected lot codes are T10 174010206, T10 174010306, T10 174010406, T10 174020206, T10 174020306 and T10 174020406. All were distributed earlier this month.

Playing an instrument may help protect brain against ageing, study finds
Playing an instrument may help protect brain against ageing, study finds

The Independent

timean hour ago

  • The Independent

Playing an instrument may help protect brain against ageing, study finds

Playing a musical instrument could help protect the brain against age-related decline, new research has suggested. Older adults with long-term musical training performed better at understanding speech in noisy environments and showed brain connectivity patterns closer to younger people, according to a study published in the journal PLOS Biology. brain activity in 25 older musicians, 25 older non-musicians and 24 young non-musicians. The participants were asked to identify syllables masked by background noise, a task that typically becomes harder with age. While older non-musicians showed the usual age-related increase in neural activity and connectivity - a sign that the brain is working harder to compensate for decline - older musicians maintained a more 'youth-like' pattern. The strength of connections in certain brain networks also correlated with better performance on the speech-in-noise task, the study found. The findings support what the researchers call the 'Hold-Back Upregulation' hypothesis. This is when the cognitive reserve built through musical training helps the brain hold onto its younger functional features, instead of simply compensating for loss. Dr Yi Du, co-author of the study, said: 'Just like a well-tuned instrument doesn't need to be played louder to be heard, the brains of older musicians stay finely tuned thanks to years of training. 'Our study shows that this musical experience builds cognitive reserve, helping their brains avoid the usual age-related overexertion when trying to understand speech in noisy places.' The authors said that although the study cannot prove cause and effect, it adds to growing evidence that positive lifestyle choices, such as musical training, higher education and bilingualism, can help the brain cope better with ageing. Dr Lei Zhang, another co-author, added: 'A positive lifestyle helps older adults cope better with cognitive ageing, and it is never too late to take up, and stick with, a rewarding hobby such as learning an instrument.' The scientists are now planning to explore whether other activities, such as exercise and multilingualism, could offer similar benefits.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store